Search for instruments
Genmab A/S
Genmab A/S is a leading biotechnology company that specializes in developing innovative antibody therapeutics for cancer treatment. Established in 1999, the company has a strong focus on research and development, with a diverse pipeline of products targeting various cancers. Its flagship product, Darzalex, is a monoclonal antibody approved for treating multiple myeloma. Genmab is also developing potential treatments for solid tumors and hematological malignancies. The company is dedicated to improving the lives of cancer patients through novel and effective therapies and is a recognized leader in the field of antibody therapeutics.Instrument specification in OANDA
Name
Currency
Symbol
Minimum order value
Ticker
Trading hours
Type
Hours of accepting orders
ISIN
Start trading now with fast account opening.
Sign-up now to trade the most active markets
Open account
Boasting over 20 years in the markets, leading analysis tools and thousands of satisfied clients, OANDA is proud to be an award-winning broker.
Get access to the most active of global markets with thousands of trading instruments at your fingertips, as well leading technical tools to assist in your analysis.
Trade without unnecessary costs and total pricing transparency - OANDA offers zero-commission on major instruments, transparent pricing.
